Skip to content

Welcome to Discover Pharma! Today is : November 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

active treatment extension

  • Clinical & Regulatory

    Neurizon advances NUZ-001 ALS trial into treatment extension

    Neurizon Therapeutics has advanced its Phase 2/3 HEALEY ALS Platform [...]

    November 17, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • PlaqueTec expands coronary artery disease trial to eight NHS centres
    Categories: Medical devices, Research & Development
  • Aravax reports positive Phase 2 results for peanut allergy immunotherapy
    Categories: Research & Development, Therapeutic Areas
  • Yourgene wins Australian approval for DPYD chemotherapy toxicity assay
    Categories: Clinical & Regulatory
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top